Tirzepatide: A new treatment option for managing obesity

From 23 June, people living with obesity may be eligible to access tirzepatide (Mounjaro®) for weight loss purposes in primary care settings.

This does not mean prescriptions will be provided immediately. It means primary care settings can begin discussions with patients about whether tirzepatide is the right option to improve their health through weight loss.

Please do not contact your GP if you think you are eligible as it will not be available in Derby and Derbyshire until later in the year.  

The ICB has the responsibility and will publish more information once a service has been set up explaining who can access it and how.

Access is prioritised for those with the greatest clinical need, it is for people living with obesity, in poor health with multiple obesity related conditions; as they would benefit most from the treatment.

Read more: Tirzepatide » Joined Up Care Derbyshire